To analyze changes in T-helper (Th) subsets, T-regulatory (Treg) cell percentages and function, and mRNA levels of immunologically relevant molecules during a 24-month follow-up after alemtuzumab treatment in patients with relapsing-remitting multiple sclerosis (RRMS).
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months
DE MERCANTI, STEFANIA FEDERICA;ROLLA, SIMONA;Cucci, Angele;BARDINA, VALENTINA;NOVELLI, Francesco;DURELLI, Luca;CLERICO, Marinella
Co-last
2016-01-01
Abstract
To analyze changes in T-helper (Th) subsets, T-regulatory (Treg) cell percentages and function, and mRNA levels of immunologically relevant molecules during a 24-month follow-up after alemtuzumab treatment in patients with relapsing-remitting multiple sclerosis (RRMS).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Alemtuzumab long-term immunologic effect_4aperto.pdf
Accesso aperto
Descrizione: Articolo principale
Tipo di file:
PDF EDITORIALE
Dimensione
527.68 kB
Formato
Adobe PDF
|
527.68 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
